Pancreatic cancer is one of the deadliest forms of cancer, with fewer than 13% of patients surviving five years after diagnosis. In 2025, scientists made significant progress toward detecting — and potentially preventing — the disease much earlier.
Researchers identified new biomarkers in blood tests that can flag pancreatic cancer at stages when it is still treatable. Early detection could transform the prognosis from near-certain death to a manageable condition.
“In 2025, scientists made significant progress toward detecting — and potentially preventing — the disease much earlier.”
Multiple research teams published findings showing that AI-assisted analysis of routine medical scans could identify precancerous changes in the pancreas years before symptoms appear. These advances represent a paradigm shift in how we approach one of medicine's most challenging cancers.
How did this story make you feel?
